Mutations in genes coding for proteins involved in Aβ clearance pathways represent risk factors for AD, among these are apolipoprotein E (APOE) and the immune receptors: triggering receptor expressed on myeloid cells 2 (TREM2), cluster of differentiation 33 (CD33), and complement region 1 (CR1). This evidence concerns the gene CD33 and Alzheimer disease.